Mimotopes of cytolytic T lymphocytes in cancer immunotherapy

Current Opinion in Immunology

Volumn 11, Issue 2, 1999, Pages 219-222

  Chen, Lieping ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; EPITOPE; PEPTIDE LIBRARY;

CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; HUMAN; SHORT SURVEY; TUMOR IMMUNITY;

EID: 0033118896     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80037-5     Document Type: Article

References (33)

1. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 1998, 396:643-649.
2. Mayrand SM, Green WR: Non-traditionally derived CTL epitopes: Exceptions that prove the rules? Immunol Today 1998, 19:551-555.
3. Boon T, Old LJ: Cancer tumor antigens. Curr Opin Immunol 1997, 9:681-683.
4. Rosenberg SA: Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol Today 1997, 18:175-182.
5. Bevan MJ: Antigen recognition. Class discrimination in the world of immunology. Nature 1987, 325:192-194.
6. Carbone FR, Kurts C, Bennett SR, Miller JF, Heath WR: Cross-presentation: A general mechanism for CTL immunity and tolerance. Immunol Today 1998, 19:368-373.
7. Schreiber H: Tumor immunology. In Fundamental Immunology, Edn 4. Edited by Paul WE. Philadelphia: Lippincott-Raven; 1999:1237-1270.
8. Ferrone S, Marincola FM: Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995, 16:487-494.
9. Staveley-O'Carroll K, Sotomayor E, Montgomery J, Borrello I, Hwang L, Gein S, Pardoll DM, Levitsky H: Induction of antigen-specific T cell anergy: An early event in the course of tumor progression. Proc Natl Acad Sci USA 1998, 95:1178-1183.
10. Adler AJ, March DW, Yochum GS, Guzzo JL, Nigam A, Nelson WG, Pardoll DM: CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med 1998, 187:1555-1564.
11. Chen L: Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunol Today 1998, 19:27-30.
12. Velders MP, Nieland JD, Rudolf MP, Loviscek K, Weijzen S, de Visser KE, Macedo MF, Carbone M, Kast WM: Identification of peptides for immunotherapy of cancer: It is worth the effort. Crit Rev Immunol 1998, 18:7-27.
13. Englehard VH: Direct identification of tumor-associated peptide antigens. Springer Semin Immunopathol 1996, 18:171-183.
14. Walden P: T-cell epitope determination. Curr Opin Immunol 1996, 8:68-74.
15. Hemmer B, Vergelli M, Pinilla C, Houghten R, Martin R: Probing degeneracy in T-cell recognition using peptide combinatorial libraries. Immunol Today 1998, 19:163-168.
16. Blake J, Johnston JV, Hellstrom KE, Marquardt H, Chen L: Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes. J Exp Med 1996, 184:121-130.
17. Gavin MA, Bavan MJ: Major histocompatibility complex allele-specific peptide libraries and identification of T-cell mimiotopes. Methods Mol Biol 1998, 87:235-297. This gives a detailed methodology for use of the randomly mutated minigene approach to construct peptide libraries.
18. Strausbauch MA, Nevala WK, Roopenian DC, Stefanski HE, Wettstein PJ: Identification of mimotopes for the H4 minor histocompatibility antigen. Int Immunol 1997, 10:421-434.
19. + cytolytic T lymphocytes. J Exp Med 1996, 183:791-800.
20. b epitope is encoded by a novel mouse Y chromosome gene. Nat Genet 1996, 14:474-478
21. + T cells.
22. Hiemstra HS, van Veelen PA, Schloot NC, Geluk A, van Meijgaarden KE, Willemen SJM, Leunissen JAM, Benckhuijsen WE, Amons R, de Vries RRP et al.: Definition of natural T cell antigens with mimicry epitopes obtained from dedicated synthetic peptide libraries. J Immunol 1998, 161:4078-4082.
23. Parkhurst MR, Salgaller ML, Southwood S, Robbins PF, Rosenberg SA, Kawakami Y: Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A * 0201-binding residues. J Immunol 1996, 157:2539-2548.
24. Sarobe P, Pendleton CD, Akatsuka T, Lau D, Engelhard VH, Feinstone SM, Berzofsky JA: Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. J Clin Invest 1998, 102:1239-1248.
25. Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topallian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ et al.: Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 1998, 4:321-327. This report describes that immunization of melanoma patients with a modified gp100 peptide with higher affinity for HLA-A2 induced better CTL responses compared to its native partner.
26. Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J: Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen. Cancer Res 1998, 57:4570-4577.
27. d-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative. J Exp Med 1997, 185:629-640.
28. + T cell clone can be increased by replacement of some amino acids following peptide-library screening.
29. Heath WR, Karamalis F, Donohue J, Miller JFAP: Autoimmunity caused by ignorant CD8+ T cells is transient and depends on avidity. J Immunol 1995, 155:2339-2346.
30. Munz C, Obst R, Osen W, Stevanovic S, Rammensee HG: Alloreactivity as a source of high avidity peptide-specific human CTL. J Immunol 1999, 162:25-34.
31. Obst R, Munz C, Stevanovic S, Rammensee HG: Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: Evidence for a functionally diverse allorestricted T cell repertoire. Eur J Immunol 1998, 28:2432-2443.
32. Sadovnikova E, Stauss HJ: Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: Reagents for tumor immunotherapy. Proc Natl Acad Sci USA 1996, 93:13114-13118.
33. Sadovnikova E, Jopling LA, Soo KS, Stauss HJ: Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self H LA class I molecules. Eur J Immunol 1998, 28:193-200.